Blend vials have become the default way people buy research peptides. Instead of four vials, four reconstitutions and four sets of numbers, you get one vial with a combined label: 80 mg, or 20 mg, or 10 mg total. It looks simpler. The math underneath is not.
The problem shows up the moment someone takes that combined figure and runs it through a standard single peptide calculation. Enter 80 mg as the vial size, add the water, get a draw volume back, and the number that comes out is correct for the vial as a whole and wrong for every individual peptide inside it. This guide covers how blend math actually works, using the two combinations people ask about most.
A blend is not one peptide with a bigger number
In a single peptide vial there is one active compound, so one concentration answers every question. A blend contains two or more compounds that were weighed out and combined before the vial was sealed. That ratio is fixed. Nothing you do afterwards changes it.
The consequence is the part people miss: you cannot dose the components independently. One draw delivers every peptide in the vial at the same time, in the proportion the manufacturer set. Doubling the volume to get more of one compound doubles all of them. This is the single biggest practical difference between running a blend and running separate vials.
So the calculation reverses. Rather than working out a draw volume for a target quantity, you work out what a given draw volume delivers of each component, then decide whether that spread is what you want.
Step one: break the vial into its components
Before touching the water, write out what is actually in the vial. Two examples cover most of the market.
The Wolverine stack pairs BPC-157 and TB-500. A common configuration is 10 mg of each, labelled as a 20 mg vial. Some suppliers sell 5 mg and 5 mg as a 10 mg vial.
KLOW combines four peptides: GHK-Cu, BPC-157, TB-500 and KPV. The widely sold configuration is 80 mg total, made up of 50 mg GHK-Cu and 10 mg each of BPC-157, TB-500 and KPV. GHK-Cu is over 60 percent of that vial by weight, which matters enormously once you start dividing.
Fills vary between suppliers. Two vials both labelled 80 mg KLOW can hold different internal ratios, and the total on the front of the vial will not tell you. Read the component breakdown, and if there is not one, you have no basis for the calculation.
Step two: calculate total concentration, then per component concentration
Total concentration works the same way as any single vial: divide the combined milligrams by the millilitres of bacteriostatic water you add.
Take an 80 mg KLOW vial reconstituted with 4 mL. That gives 20 mg per mL of total peptide. Now split that by the ratio inside the vial:
- GHK-Cu: 50 mg of 80 mg, so 12.5 mg per mL
- BPC-157: 10 mg of 80 mg, so 2.5 mg per mL
- TB-500: 10 mg of 80 mg, so 2.5 mg per mL
- KPV: 10 mg of 80 mg, so 2.5 mg per mL
Those four numbers, not the 20 mg per mL headline, are what any real decision rests on.
Step three: find what one draw delivers
Multiply each component concentration by your draw volume. On a U-100 insulin syringe, one unit is 0.01 mL, so 10 units is 0.1 mL.
At 0.1 mL from that KLOW vial you get:
- GHK-Cu: 1,250 mcg
- BPC-157: 250 mcg
- TB-500: 250 mcg
- KPV: 250 mcg
The Wolverine stack is cleaner because the ratio is even. A 20 mg vial holding 10 mg of each, reconstituted with 2 mL, gives 10 mg per mL total and 5 mg per mL of each peptide. A 0.05 mL draw, which is 5 units, delivers 250 mcg of BPC-157 and 250 mcg of TB-500. When components are split evenly, the per component quantity is simply the total draw divided by the number of peptides.
The limiting component decides your volume
Here is where blends force a genuine trade-off. Suppose you want 500 mcg of BPC-157 out of that KLOW vial. BPC-157 sits at 2.5 mg per mL, so you need 0.2 mL, which is 20 units. That same 0.2 mL also delivers 2,500 mcg of GHK-Cu, whether or not that suits you.
You cannot pull the two apart. The volume is driven by whichever component you consider the priority, and everything else follows at whatever the ratio dictates. Choose the component that matters most, calculate the volume from that one, then check what the others land at. If the result is unworkable, the answer is a different blend ratio or separate vials, not a different reconstitution.
This is also the honest way to compare blends before buying. Two products with identical totals can behave completely differently, because the ratio determines what you can actually reach. Compare component breakdowns, not headline milligrams.
Four errors specific to blends
- Running the total through a single peptide calculation. Entering 80 mg as the vial size produces a draw volume for 80 mg of undifferentiated peptide. It tells you nothing about the 10 mg of KPV inside.
- Assuming an even split. Wolverine stacks usually are even. KLOW is not, and treating it as four equal quarters overstates three components and badly understates GHK-Cu.
- Carrying units across vials. Ten units of one blend is not ten units of another. Change the total, the water volume or the internal ratio and every previous number is void.
- Scaling one component in isolation. Increasing the draw to raise one peptide raises all of them by the same factor. There is no way to adjust a single component inside a sealed blend.
Half-lives do not blend
One more thing the ratio does not control. Peptides that enter together do not leave together, because each clears at its own rate. Over a repeated schedule, shorter acting components fall away between draws while longer acting ones build up, so the balance in circulation drifts away from the ratio printed on the vial.
That gap widens the longer a schedule runs. Anyone modelling a blend across weeks rather than a single draw needs the half-life of each component separately, which is a different calculation from the concentration math above.
Running the numbers
Blend arithmetic is repetitive rather than difficult, and repetitive arithmetic is exactly where transcription slips happen. A peptide calculator that handles blends will take each component, the water volume and your target, then return the concentration and per draw quantity for every peptide in the vial, along with the draw volume in millilitres and syringe units. It also covers half-life accumulation across a schedule, which is the part that is genuinely tedious to work out by hand.
Whichever way you calculate it, record the component breakdown and the reconstitution volume together and keep them with the vial. A draw volume written down without the ratio it came from is meaningless a fortnight later.
What the math cannot tell you
These calculations answer one question: given this vial and this much water, how much of each peptide is in a given volume of liquid. They do not indicate whether a blend is appropriate, whether a particular ratio makes sense, or how the components interact.
Peptides sold in this category are laboratory materials and carry no approval for human use. Blends compound the usual uncertainty, because the evidence base for individual peptides is thin and the evidence for specific combinations is thinner still. Get the arithmetic right, document every vial, and treat the calculator as a measurement tool rather than a protocol.
